Classic Recovery
Goal · Tendon, ligament, and soft-tissue recovery research.
BPC-157 + TB-500 is the most commonly cited recovery research stack across community protocols, on the theory of complementary mechanisms: BPC-157 drives angiogenesis and growth-hormone-receptor upregulation at injury sites; TB-500 sequesters G-actin to promote endothelial-cell and stem-cell migration into those sites. Animal-model evidence is strong for each component separately; no published RCT validates the specific combination.
COMPONENTS
Angiogenesis + cytoprotection at injury site
Actin-cytoskeleton-driven cell migration + anti-fibrotic
CYCLE FRAMING
4–6 weeks loading, 4 weeks maintenance per community protocols
RESEARCH NOTE
No published RCT validates this combination. Per-component animal-model dose ranges do not translate to a human recommendation.
SOURCED FROM PEPPU LABS
Each component is available individually as research-grade material at Peppu Studio · ≥99% purity · per-batch CoA. For laboratory research use only. No human dose is recommended.
SOURCE COMPONENTS ▶